Gangliosides and Cholesterol: Dual Regulators of Neuronal Membrane Framework in Autism Spectrum Disorder
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1322 - 1322
Published: Feb. 4, 2025
Autism
spectrum
disorder
(ASD)
is
a
neurodevelopmental
with
heterogeneous
clinical
presentation.
Diagnosing
ASD
complex,
and
the
criteria
for
diagnosis,
as
well
term
ASD,
have
changed
during
last
decades.
Diagnosis
made
based
on
observation
accomplishment
of
specific
diagnostic
criteria,
while
particular
biomarker
does
not
yet
exist.
However,
studies
universally
report
disequilibrium
in
membrane
lipid
content,
pointing
to
unique
neurolipid
signature
ASD.
This
review
sheds
light
possible
role
cholesterol
gangliosides,
complex
glycosphingolipids,
development
In
addition
maintaining
integrity,
neuronal
signaling,
synaptic
plasticity,
these
lipids
play
neurotransmitter
release
calcium
signaling.
Evidence
linking
lipidome
changes
includes
low
levels,
unusual
ganglioside
metabolic
profiles.
symptoms
may
be
mitigated
therapeutic
interventions
targeting
composition
membranes.
restoring
equilibrium
central
nervous
system
remains
challenge.
underscores
need
comprehensive
research
into
metabolism
uncover
practical
insights
etiology
treatment
lipidomics
emerges
major
area
research.
Language: Английский
The Bioactive Sphingolipid Playbook. A Primer for the Uninitiated as well as Sphingolipidologists
Journal of Lipid Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100813 - 100813
Published: April 1, 2025
Language: Английский
Apolipoprotein M expression modifies the sphingolipid landscape in murine blood and lymph
Victoria A. Blaho,
No information about this author
Joshua T. Minyard
No information about this author
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 2, 2025
Members
of
the
diverse
family
sphingolipids
(SPL),
such
as
ceramides
(Cer)
and
sphingomyelins
(SM),
are
well-known
structural
bioactive
signaling
molecules.
A
key
SPL
member
critical
lipid,
sphingosine
1-phosphate
(S1P),
is
carried
in
blood
primarily
by
its
“chaperone”
protein
apolipoprotein
M
(ApoM)
on
high-density
lipoprotein
(HDL)
particles.
S1P
has
been
shown
to
regulate
biological
pathways
through
specific
G
protein-coupled
receptor
(GPCR)
that
can
be
modulated
based
upon
chaperone:
ApoM
or
albumin.
Blood
concentrations
itself
altered
human
diseases
coronary
artery
disease,
type
I
II
diabetes,
systemic
lupus
erythematosus,
have
also
linked
changes
other
species;
however,
studies
measuring
molecules
only
while
neglecting
lymph
may
excluding
clues
physiology
affected
multiorgan
metabolic
pathways.
Comparing
SM,
dihydroSM,
Cer,
dihydroCer,
α-hydroxy
Cer
(αOHCer),
(C1P),
(Sph)/dihydroSph,
S1P/dihydroS1P,
diacylglycerol
(DAG)
wild-type
mouse
plasmas
with
those
mice
lacking
expressing
a
transgene
ApoM,
we
describe
unanticipated
differences
between
sphingolipidomes
their
ApoM-responsive
lipid
species.
Of
100
unique
species
targeted,
97
were
identified
94
lymph.
Some
most
striking
findings
lymph,
where
αOHCer
previously
unidentified
major
constituent.
This
report
provides
resource
starting
point
for
further
investigations
into
contributions
circulating
sphingolipidome
homeostasis
disease.
Language: Английский